Novo Nordisk flags flutter outside their office in Bagsvaerd, on the outskirts of Copenhagen, Denmark, July 14, 2025.A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions.A closely watched pill from Novo Nordisk just scored an approval for another use: slashing cardiovascular risks.The step further confirms that highly popular GLP-1s, both oral and injectable versions, have oth ...